Researchers at Scientific Institute IRCCS E. MEDEA Have Published New Data on Friedreich Ataxia (A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients).

Předmět:	ATAXIA CENTRAL nervous system diseases RESEARCH personnel NEUROLOGICAL disorders FRIEDREICH'S ataxia CEREBELLUM degeneration
Zdroj:	Clinical Trials Week; 9/9/2024, p1043-1043, 1p
Abstrakt:	The article reports on a pilot phase 2 trial evaluating etravirine, an anti-HIV drug, for its potential to treat Friedreich Ataxia (FRDA). Topics discussed include the drug's safety and tolerability, its effects on neurological function and exercise performance, and the changes in various health measures during the trial.
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu